These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 2174672
1. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast. Crissman JD, Visscher DW, Kubus J. Arch Pathol Lab Med; 1990 Dec; 114(12):1249-53. PubMed ID: 2174672 [Abstract] [Full Text] [Related]
2. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma. Chen TL, Luo I, Mikhail N, Rasková J, Raska K. Cytometry; 1995 Sep 15; 22(3):181-9. PubMed ID: 8556949 [Abstract] [Full Text] [Related]
3. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL. APMIS Suppl; 2003 Sep 15; (108):1-67. PubMed ID: 12874968 [Abstract] [Full Text] [Related]
4. A comparative morphometric and cytophotometric study of intraductal hyperplasia and intraductal carcinoma of the breast. Norris HJ, Bahr GF, Mikel UV. Anal Quant Cytol Histol; 1988 Feb 15; 10(1):1-9. PubMed ID: 2833287 [Abstract] [Full Text] [Related]
5. Prognostic significance of image cytometry DNA parameters in tissue sections from breast and gastric cancers. Haroske G, Kunze KD, Theissig F. Anal Cell Pathol; 1991 Jan 15; 3(1):11-24. PubMed ID: 1848088 [Abstract] [Full Text] [Related]
6. Expression of c-erb B-2 protein and DNA ploidy in breast carcinogenesis. Schmitt FC, Figueiredo P, Lacerda M. Arch Pathol Lab Med; 1995 Sep 15; 119(9):815-20. PubMed ID: 7668939 [Abstract] [Full Text] [Related]
7. Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma. Kysela B, Siracký J, Redecha M, Bárdos A. Neoplasma; 1990 Sep 15; 37(5):489-95. PubMed ID: 2234210 [Abstract] [Full Text] [Related]
8. Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry. Lee AK, Wiley B, Dugan JM, Hamilton WH, Loda M, Heatley GJ, Cook L, Silverman ML. Pathol Res Pract; 1992 Jun 15; 188(4-5):428-32. PubMed ID: 1329051 [Abstract] [Full Text] [Related]
9. Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Keohavong P, Gao WM, Mady HH, Kanbour-Shakir A, Melhem MF. Cancer Lett; 2004 Aug 20; 212(1):121-30. PubMed ID: 15246568 [Abstract] [Full Text] [Related]
10. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast. Tsuda H, Takarabe T, Akashi-Tanaka S, Fukutomi T, Hirohashi S. Mod Pathol; 2001 May 20; 14(5):382-8. PubMed ID: 11353046 [Abstract] [Full Text] [Related]
11. Nuclear cytometric changes in breast carcinogenesis. Mommers EC, Poulin N, Sangulin J, Meijer CJ, Baak JP, van Diest PJ. J Pathol; 2001 Jan 20; 193(1):33-9. PubMed ID: 11169513 [Abstract] [Full Text] [Related]
12. p53 protein expression and nuclear DNA content in breast intraductal proliferations. Schmitt FC, Leal C, Lopes C. J Pathol; 1995 Jul 20; 176(3):233-41. PubMed ID: 7674086 [Abstract] [Full Text] [Related]
13. Immunoreactivity with monoclonal antibody A-80 and nuclear DNA content in benign and malignant human breast disease. Eriksson E, Schimmelpenning H, Silfverswärd C, Auer G. Hum Pathol; 1992 Dec 20; 23(12):1366-72. PubMed ID: 1468773 [Abstract] [Full Text] [Related]
14. Value of cytometric analysis for distinction of intraductal carcinoma of the breast. Fisher ER, Siderits R. Breast Cancer Res Treat; 1992 Dec 20; 21(3):165-72. PubMed ID: 1325216 [Abstract] [Full Text] [Related]
15. [Image analytic DNA cytometry--a possibility for assessment of prognosis after resection of ductal pancreatic cancers?]. Böttger T, Störkel S, Stöckle M, Gerber B, Junginger T. Chirurg; 1991 Oct 20; 62(10):725-30; discussion 731. PubMed ID: 1662128 [Abstract] [Full Text] [Related]
16. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. Larson PS, de las Morenas A, Cerda SR, Bennett SR, Cupples LA, Rosenberg CL. J Pathol; 2006 Jul 20; 209(3):307-16. PubMed ID: 16604511 [Abstract] [Full Text] [Related]
17. Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast. Hoque A, Lippman SM, Boiko IV, Atkinson EN, Sneige N, Sahin A, Weber DM, Risin S, Lagios MD, Schwarting R, Colburn WJ, Dhingra K, Follen M, Kelloff GJ, Boone CW, Hittelman WN. Cancer Epidemiol Biomarkers Prev; 2001 Mar 20; 10(3):249-59. PubMed ID: 11303595 [Abstract] [Full Text] [Related]
18. [Morphological possibilities for objectification of the prognosis for invasive ductal carcinoma of the breast]. Theissig F, Haroske G, Dimmer V, Kunze KD, Meyer W. Zentralbl Pathol; 1991 Mar 20; 137(3):242-8. PubMed ID: 1718409 [Abstract] [Full Text] [Related]
19. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast. Lininger RA, Zhuang Z, Man Y, Park WS, Emmert-Buck M, Tavassoli FA. Mod Pathol; 1999 Dec 20; 12(12):1083-9. PubMed ID: 10619258 [Abstract] [Full Text] [Related]
20. [Contents of nuclear Feulgen-DNA in carcinoma of the breast. Cytophotometric analysis]. Ricevuti G, Barni S. Arch Sci Med (Torino); 1983 Dec 20; 140(4):393-400. PubMed ID: 6201153 [Abstract] [Full Text] [Related] Page: [Next] [New Search]